ELABELA Ameliorates Atherosclerosis Through Restoring the M1/M2 Macrophage Balance in ApoE−/− Mice
Background Atherosclerosis is a progressive arterial disease characterized by chronic inflammation and plaque formation in blood vessel walls. ELABELA, an endogenous ligand for the G protein‐coupled receptor APJ (apelin peptide jejunum, apelin receptor), has multiple pharmacological activities for p...
Saved in:
| Main Authors: | Le Tang, Xiaoli Yi, Wenting Tan, Huiru Yang, Shanshan Song, Jianhua Xiong, Chunju Liu, Yifeng Zhang, Mulan Wang, Mengzhi Zhu, Lixiang Zheng, Jun Yu, Chuanming Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.041261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: I. S. Mykhailichenko
Published: (2016-04-01) -
Research advances of Elabela in kidney disease
by: Wang Zi-wei, et al.
Published: (2021-01-01) -
Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
by: Layla Imad Ali, et al.
Published: (2025-06-01) -
Maternal Plasma Elabela, a Biomarker for the Severity and Kidney Function of Human Preeclampsia
by: Miaoyan Ma, et al.
Published: (2022-09-01) -
The potential of serum elabela levels as a marker of diabetic retinopathy: results from a pilot cross-sectional study
by: Muhammed Seyithanoğlu, et al.
Published: (2025-01-01)